To determine the potential anti‐tumour effects of BRD7‐targeted demethylation in NPC, we conducted in vitro experiments using NPC cells stably expressing dCas9‐TET1CD‐sgRNA2&5. This evidence concerns the gene BRD7 and nasopharyngeal carcinoma.